stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Savara IncSVRA
$4.2618.23%-0.95

Savara Inc (SVRA)

Savara Inc stock is traded at $4.26, with a volume of 17,008,338. It is down -18.23% in the last 24 hours and down -10.50% over the past month. Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Previous Close:
$5.21
Open:
$4.19
24h Volume:
17,008,338
Relative Volume:
2.72
Market Cap:
$939.86M
Revenue:
-
Net Income/Loss:
-$129.48M
P/E Ratio:
-
EPS:
-$0.5584
Net Cash Flow:
-$106.97M
1W Performance:
-8.19%
1M Performance:
-10.50%
6M Performance:
-16.14%
1Y Performance:
-8.78%
1-Day Range:
$4.00$4.52
1-Week Range:
$4.00$5.34
52-Week Range:
$4.00$7.01

Savara Inc Stock (SVRA) Company Profile

Name
Savara Inc
Phone
51285113796
Address
6836 BEE CAVE ROAD, AUSTIN, TX, USA
Employee
70
Next Earnings Date
-
Latest SEC Filings
SEC
SVRA's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Savara Inc Stock (SVRA) Financials Data

Similar to SVRA